Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States
Authors:
- 24 November 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (9) , 2327-2337.e9
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- NCI (R01 MD012565, U01 CA230694)
- Cancer Prevention and Research Institute of Texas (RP170259)
This publication has 31 references indexed in Scilit:
- Hepatocellular carcinoma: early-stage management challengesJournal of Hepatocellular Carcinoma, 2017
- Affordable Care Act Changes To Medicare Led To Increased Diagnoses Of Early-Stage Colorectal Cancer Among SeniorsHealth Affairs, 2017
- Return to work among breast cancer survivors: A literature reviewSupportive Care in Cancer, 2016
- Financial Hardships Experienced by Cancer Survivors: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2016
- Gender differences in associations between cancer-related problems and relationship dissolution among cancer survivorsJournal of Cancer Survivorship, 2016
- Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosisCancer, 2015
- Medical Care Costs and Survival Associated With Hepatocellular Carcinoma Among the ElderlyClinical Gastroenterology and Hepatology, 2012
- Forgoing medical care because of costCancer, 2010
- The burden of illness associated with hepatocellular carcinoma in the United StatesJournal of Hepatology, 2009
- The surveillance, epidemiology, and end results program: a national resource.1999